MENU
KPTI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Karyopharm Therapeutics (KPTI) Ownership - Who owns Karyopharm Therapeutics?
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
32.99M
P/E Ratio
N/A
Total Cash
108.71M
Projected Growth
N/A
Total Debt
194.52M
Revenue
145.24M
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash/Share
12.92
Total Debt/Equity
N/A
Revenue/Share
17.18 USD as % of share price
Fundamentals
KPTI
Capitalization
33M
P/E Ratio
N/A
Risk (Beta)
0.97
Dividend Yield
N/A
Total Cash
109M
Total Cash/Share
12.92
Total Debt
195M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
17.18%
Revenue
145M
ROE
N/A
Book Value
-186.02M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-9.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
1.70
Current Revenue Per Employee
109469.53
Dividends Per Share - Security
N/A
EBITDA
-38.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.64
Revenue To Assets
-37.75
Shares Held By Institutions
50.8M
Shares Outstanding - Current
8.42M
Total Liabilities
350M
Total Volume MTD
N/A
Value
1
Gain YTD
-61.950
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com